Psyence Biomedical Ltd. PBM
Set alert
3.18 USD -0.13 -3.93%
At close
3.02 -0.16 -5.03%
Pre-market · Nov 3, 4:03 AM ET
3.16 Day range 3.55
1.92 52-week range 116.41
- YTD
- -89.19%
- 1 year
- -97.29%
- Open
- 3.36
- Prev close
- 3.31
- Mkt cap
- 12.13M
- Vol
- 116.09K
- Avg vol
- 79.10K
- EPS
- -12.56
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.16
- High
- 3.55
- Forward P/E
- 0.00
- Beta
- -0.42
- Short ratio
- 0.08
- Inst. own
- 37.09%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 4.68
- 200-d avg
- 36.44
- 1y target
- 0.00
Financial health
Altman Z-Score
-6.25 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.2×
FY 2020 5y median -0.2× FY 2025
P/S 0.0×
FY 2020 5y median 0.0× FY 2025
P/B 0.1×
FY 2020 5y median 2.1× FY 2025
P/FCF -0.2×
FY 2020 5y median -7930× FY 2025
EV/EBITDA 0.9×
FY 2020 5y median 8.0× FY 2025
EV/Sales 0.0×
FY 2020 5y median 0.0× FY 2025
FCF Yield -636.2%
FY 2020 5y median -0.0% FY 2025
Profitability
Gross Margin 0.0%
FY 2020 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2020 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2020 5y median 0.0% FY 2025
ROE -40.9%
FY 2020 5y median 3.5% FY 2025
ROIC -36.8%
FY 2020 5y median -1.8% FY 2025
ROA -39.5%
FY 2020 5y median 2.5% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2020 FY 2025
Operating Income -70.3%
FY 2020 FY 2025
EPS (diluted) -805.6%
FY 2020 FY 2025
Free Cash Flow -130.8%
FY 2020 FY 2025
Financial Health
Current Ratio 14.6×
FY 2020 5y median 5.6× FY 2025
Quick Ratio 14.6×
FY 2020 5y median 5.9× FY 2025
Debt / Equity 0.0×
FY 2020 5y median 0.0× FY 2025
Net Debt / EBITDA 1.1×
FY 2020 5y median -0.0× FY 2025
Interest Coverage -655×
FY 2020 5y median -52.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2020 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2020 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2026-03-31